Eric Eisenhauer

5.5k total citations · 2 hit papers
79 papers, 3.0k citations indexed

About

Eric Eisenhauer is a scholar working on Reproductive Medicine, Surgery and Obstetrics and Gynecology. According to data from OpenAlex, Eric Eisenhauer has authored 79 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Reproductive Medicine, 45 papers in Surgery and 39 papers in Obstetrics and Gynecology. Recurrent topics in Eric Eisenhauer's work include Ovarian cancer diagnosis and treatment (52 papers), Endometrial and Cervical Cancer Treatments (33 papers) and Intraperitoneal and Appendiceal Malignancies (31 papers). Eric Eisenhauer is often cited by papers focused on Ovarian cancer diagnosis and treatment (52 papers), Endometrial and Cervical Cancer Treatments (33 papers) and Intraperitoneal and Appendiceal Malignancies (31 papers). Eric Eisenhauer collaborates with scholars based in United States, Canada and Italy. Eric Eisenhauer's co-authors include S. Dennis, Nadeem R. Abu‐Rustum, Yukio Sonoda, Richard R. Barakat, Douglas A. Levine, Robert E. Bristow, Carol Aghajanian, Oliver Zivanovic, Antonio Santillan and Jae Huh and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Obstetrics and Gynecology and British Journal of Cancer.

In The Last Decade

Eric Eisenhauer

75 papers receiving 3.0k citations

Hit Papers

What is the optimal goal of primary cytoreductive surgery... 2006 2026 2012 2019 2006 2009 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
    2006 465 citations Eric Eisenhauer, Jae Huh et al. Gynecologic Oncology profile →
  2. Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm
    2009 441 citations S. Dennis, Eric Eisenhauer et al. Gynecologic Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Eisenhauer United States 26 2.4k 1.9k 1.3k 514 351 79 3.0k
Valerio Gallotta Italy 40 2.8k 1.2× 2.3k 1.2× 2.5k 1.9× 784 1.5× 506 1.4× 185 4.5k
Suk‐Joon Chang South Korea 22 1.6k 0.7× 1.1k 0.6× 1.3k 1.0× 374 0.7× 197 0.6× 135 2.3k
Gerardo Zanetta Italy 30 2.1k 0.9× 1.0k 0.5× 1.5k 1.1× 497 1.0× 428 1.2× 80 3.1k
Patricia Pautier France 36 2.9k 1.2× 1.2k 0.6× 1.8k 1.4× 761 1.5× 391 1.1× 169 4.1k
Damienne Castaigne France 36 2.2k 0.9× 1.1k 0.6× 1.7k 1.3× 558 1.1× 268 0.8× 110 3.4k
Scott M. Eisenkop United States 22 2.8k 1.2× 2.1k 1.1× 2.4k 1.9× 380 0.7× 467 1.3× 41 3.9k
Lois Almadrones United States 28 1.8k 0.8× 1.4k 0.7× 656 0.5× 929 1.8× 259 0.7× 62 2.7k
Samuel S. Lentz United States 26 1.8k 0.7× 1.5k 0.8× 2.6k 2.0× 712 1.4× 372 1.1× 60 3.8k
Michele Peiretti Italy 22 1.1k 0.5× 823 0.4× 1.0k 0.8× 389 0.8× 211 0.6× 51 1.9k
M. van Lent Netherlands 18 3.1k 1.3× 1.3k 0.7× 2.6k 2.0× 528 1.0× 361 1.0× 35 3.9k

Countries citing papers authored by Eric Eisenhauer

Since Specialization
Citations

This map shows the geographic impact of Eric Eisenhauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Eisenhauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Eisenhauer more than expected).

Fields of papers citing papers by Eric Eisenhauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Eisenhauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Eisenhauer. The network helps show where Eric Eisenhauer may publish in the future.

Co-authorship network of co-authors of Eric Eisenhauer

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Eisenhauer. A scholar is included among the top collaborators of Eric Eisenhauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Eisenhauer. Eric Eisenhauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bregar, Amy, Marcela G. del Carmen, Eric Eisenhauer, et al.. (2024). The association of maintenance hormone therapy with overall survival in advanced-stage low-grade serous ovarian carcinoma: A risk-set matched retrospective study. Gynecologic Oncology. 190. 119–123. 1 indexed citations
2.
Eisenhauer, Eric, et al.. (2023). Minimally invasive interval cytoreductive surgery for advanced ovarian cancer. Journal of Surgical Oncology. 129(1). 126–127.
3.
Matoba, Yusuke, Eugene Kim, Amy Bregar, et al.. (2023). Mechanisms of resistance to bispecific T-cell engager therapy for ovarian cancer.. Journal of Clinical Oncology. 41(16_suppl). 5571–5571. 1 indexed citations
4.
Rauh‐Hain, Jose Alejandro, Alexander Melamed, Whitfield B. Growdon, et al.. (2022). Guideline-Discordant Care in Early-Stage Vulvar Cancer. Obstetrics and Gynecology. 140(6). 1031–1041. 1 indexed citations
5.
Eisenhauer, Eric, et al.. (2019). Screening and surgical prophylaxis for hereditary cancer syndromes with high risk of endometrial and ovarian cancer. Journal of Surgical Oncology. 120(5). 864–872. 9 indexed citations
6.
Cohn, David E., Laura Huffman, Ritu Salani, et al.. (2016). A Prospective, Comparative Study for the Evaluation of Postoperative Pain and Quality of Recovery in Patients Undergoing Robotic Versus Open Hysterectomy for Staging of Endometrial Cancer. Journal of Minimally Invasive Gynecology. 23(3). 429–434. 18 indexed citations
7.
Atri, Mostafa, Zheng Zhang, Farrokh Dehdashti, et al.. (2016). Utility of PET-CT to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN6671/GOG0233 trial. Gynecologic Oncology. 142(3). 413–419. 66 indexed citations
8.
Cowan, Renee A., Destin Black, Lien Hoang, et al.. (2016). A pilot study of topical imiquimod therapy for the treatment of recurrent extramammary Paget's disease. Gynecologic Oncology. 142(1). 139–143. 49 indexed citations
9.
Liang, Margaret, Kellie S. Rath, Erinn M. Hade, et al.. (2015). Predicting Inpatient Stay Lasting 2 Midnights or Longer After Robotic Surgery for Endometrial Cancer. Journal of Minimally Invasive Gynecology. 22(4). 583–589. 7 indexed citations
10.
Eskander, Ramez N., Shamshad Ali, Thanh H. Dellinger, et al.. (2015). Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma. International Journal of Gynecological Cancer. 26(1). 125–132. 19 indexed citations
11.
Jackson, Amanda, Eric Eisenhauer, & Thomas J. Herzog. (2015). Emerging therapies: angiogenesis inhibitors for ovarian cancer. Expert Opinion on Emerging Drugs. 20(2). 331–346. 28 indexed citations
12.
Eisenhauer, Eric, Vanna Zanagnolo, David E. Cohn, et al.. (2014). A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancer. Gynecologic Oncology. 134(2). 262–266. 16 indexed citations
13.
Sandadi, Samith, K. Long, Vaagn Andikyan, et al.. (2013). Postoperative outcomes among patients undergoing thoracostomy tube placement at time of diaphragm peritonectomy or resection during primary cytoreductive surgery for ovarian cancer. Gynecologic Oncology. 132(2). 299–302. 13 indexed citations
14.
McCann, Georgia A., Gary Phillips, Eric Eisenhauer, et al.. (2012). The impact of close surgical margins after radical hysterectomy for early-stage cervical cancer. Gynecologic Oncology. 128(1). 44–48. 35 indexed citations
15.
Nagel, Christa, Floor Backes, Erinn M. Hade, et al.. (2011). Effect of chemotherapy delays and dose reductions on progression free and overall survival in the treatment of epithelial ovarian cancer. Gynecologic Oncology. 124(2). 221–224. 38 indexed citations
16.
Dennis, S., Oliver Zivanovic, Eric Eisenhauer, et al.. (2008). A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma. Gynecologic Oncology. 112(1). 6–10. 73 indexed citations
17.
Dennis, S., Yukio Sonoda, Nadeem R. Abu‐Rustum, et al.. (2007). Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma. Gynecologic Oncology. 108(1). 191–194. 54 indexed citations
18.
Eisenhauer, Eric, et al.. (2007). Comparing Surgical Outcomes in Obese Women Undergoing Laparotomy, Laparoscopy, or Laparotomy With Panniculectomy for the Staging of Uterine Malignancy. Annals of Surgical Oncology. 14(8). 2384–2391. 55 indexed citations
19.
Eisenhauer, Eric, Michael I. D’Angelica, Nadeem R. Abu‐Rustum, et al.. (2006). Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer. Gynecologic Oncology. 103(3). 871–877. 56 indexed citations
20.
Eisenhauer, Eric, Nadeem R. Abu‐Rustum, Yukio Sonoda, et al.. (2006). The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC–IV epithelial ovarian cancer. Gynecologic Oncology. 103(3). 1083–1090. 258 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valerio Gallotta Breakdown of academic impact, for papers by Suk‐Joon Chang Breakdown of academic impact, for papers by Gerardo Zanetta Breakdown of academic impact, for papers by Patricia Pautier Breakdown of academic impact, for papers by Damienne Castaigne Breakdown of academic impact, for papers by Scott M. Eisenkop Breakdown of academic impact, for papers by Lois Almadrones Breakdown of academic impact, for papers by Samuel S. Lentz Breakdown of academic impact, for papers by Michele Peiretti Breakdown of academic impact, for papers by M. van Lent
Rankless by CCL
2026